Answers are grounded in this paper and cite their sources.
Transfusion support of children with ABOiHT varies widely among blood banks in the United States and Canada. The choice of blood products and modifications utilized, titer thresholds for organ selection and medical decision points, and antibody reduction strategies are not standardized from center to center. As pediatric ABOiHTs become more common, a better understanding of optimal transfusion support and therapeutic intervention is needed.
No takes yet. Share an insight, caveat, or question.
Dean et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: